Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

NASDAQ:HLMN - Nasdaq - US4316361090 - Common Stock - Currency: USD

7.155  -0.08 (-1.17%)

Fundamental Rating

4

Overall HLMN gets a fundamental rating of 4 out of 10. We evaluated HLMN against 128 industry peers in the Machinery industry. While HLMN is still in line with the averages on profitability rating, there are concerns on its financial health. HLMN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HLMN had positive earnings in the past year.
In the past year HLMN had a positive cash flow from operations.
HLMN had negative earnings in 4 of the past 5 years.
HLMN had a positive operating cash flow in 4 of the past 5 years.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of HLMN (0.79%) is worse than 66.41% of its industry peers.
HLMN has a Return On Equity of 1.56%. This is in the lower half of the industry: HLMN underperforms 65.63% of its industry peers.
The Return On Invested Capital of HLMN (2.72%) is worse than 67.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLMN is significantly below the industry average of 10.67%.
The last Return On Invested Capital (2.72%) for HLMN is above the 3 year average (1.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROIC 2.72%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

With a Profit Margin value of 1.24%, HLMN is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
With a Operating Margin value of 5.91%, HLMN perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
In the last couple of years the Operating Margin of HLMN has grown nicely.
Looking at the Gross Margin, with a value of 47.90%, HLMN belongs to the top of the industry, outperforming 89.84% of the companies in the same industry.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLMN is destroying value.
Compared to 1 year ago, HLMN has more shares outstanding
Compared to 5 years ago, HLMN has more shares outstanding
HLMN has a better debt/assets ratio than last year.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.55, we must say that HLMN is in the distress zone and has some risk of bankruptcy.
HLMN's Altman-Z score of 1.55 is on the low side compared to the rest of the industry. HLMN is outperformed by 75.00% of its industry peers.
The Debt to FCF ratio of HLMN is 8.77, which is on the high side as it means it would take HLMN, 8.77 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.77, HLMN perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that HLMN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.60, HLMN is not doing good in the industry: 61.72% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Altman-Z 1.55
ROIC/WACC0.3
WACC8.99%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.46 indicates that HLMN has no problem at all paying its short term obligations.
HLMN has a Current ratio of 2.46. This is in the better half of the industry: HLMN outperforms 64.06% of its industry peers.
A Quick Ratio of 0.79 indicates that HLMN may have some problems paying its short term obligations.
The Quick ratio of HLMN (0.79) is worse than 76.56% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 0.79
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

HLMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.18%, which is quite good.
The Revenue has been growing slightly by 0.31% in the past year.
The Revenue has been growing slightly by 3.93% on average over the past years.
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%

3.2 Future

HLMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.20% yearly.
The Revenue is expected to grow by 4.50% on average over the next years.
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y16.2%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.5%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.76 indicates a correct valuation of HLMN.
Compared to the rest of the industry, the Price/Earnings ratio of HLMN indicates a rather cheap valuation: HLMN is cheaper than 84.38% of the companies listed in the same industry.
HLMN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.25.
HLMN is valuated correctly with a Price/Forward Earnings ratio of 12.99.
HLMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLMN is cheaper than 75.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, HLMN is valued a bit cheaper.
Industry RankSector Rank
PE 13.76
Fwd PE 12.99
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 75.00% of the companies listed in the same industry.
HLMN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HLMN is cheaper than 67.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.05
EV/EBITDA 9.61
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

HLMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y2.92%
EPS Next 3Y10.75%

0

5. Dividend

5.1 Amount

HLMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (6/2/2025, 2:52:04 PM)

7.155

-0.08 (-1.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners101.7%
Inst Owner Change4.67%
Ins Owners1.05%
Ins Owner Change4.17%
Market Cap1.41B
Analysts78.57
Price Target10.93 (52.76%)
Short Float %2.52%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.25%
Min EPS beat(2)-7.7%
Max EPS beat(2)1.2%
EPS beat(4)2
Avg EPS beat(4)0.8%
Min EPS beat(4)-7.7%
Max EPS beat(4)11.6%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)9
Avg EPS beat(12)35.03%
EPS beat(16)11
Avg EPS beat(16)166.29%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)-0.57%
Revenue beat(8)0
Avg Revenue beat(8)-2.52%
Revenue beat(12)0
Avg Revenue beat(12)-2.85%
Revenue beat(16)2
Avg Revenue beat(16)-1.93%
PT rev (1m)-8.54%
PT rev (3m)-20.82%
EPS NQ rev (1m)-3.36%
EPS NQ rev (3m)-12.17%
EPS NY rev (1m)1.12%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-1.11%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 13.76
Fwd PE 12.99
P/S 0.95
P/FCF 17.05
P/OCF 8.26
P/B 1.2
P/tB N/A
EV/EBITDA 9.61
EPS(TTM)0.52
EY7.27%
EPS(NY)0.55
Fwd EY7.7%
FCF(TTM)0.42
FCFY5.87%
OCF(TTM)0.87
OCFY12.1%
SpS7.5
BVpS5.98
TBVpS-1.2
PEG (NY)1.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.56%
ROCE 4.18%
ROIC 2.72%
ROICexc 2.76%
ROICexgc 8.92%
OM 5.91%
PM (TTM) 1.24%
GM 47.9%
FCFM 5.59%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexcg growth 3Y110.94%
ROICexcg growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 8.77
Debt/EBITDA 3.23
Cap/Depr 66.13%
Cap/Sales 5.95%
Interest Coverage 1.94
Cash Conversion 77.46%
Profit Quality 449.74%
Current Ratio 2.46
Quick Ratio 0.79
Altman-Z 1.55
F-Score7
WACC8.99%
ROIC/WACC0.3
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y8.13%
EPS Next 2Y2.92%
EPS Next 3Y10.75%
EPS Next 5Y16.2%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%2.58%
Revenue Next Year4.26%
Revenue Next 2Y5.41%
Revenue Next 3Y4.96%
Revenue Next 5Y4.5%
EBIT growth 1Y14.99%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year150.04%
EBIT Next 3Y40.67%
EBIT Next 5Y27.35%
FCF growth 1Y5.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.97%
OCF growth 3YN/A
OCF growth 5Y28.46%